Neuropathic pain assessment: Update on laboratory diagnostic tools

Current Opinion in Anaesthesiology

Volumn 28, Issue 5, 2015, Pages 537-545

  Mainka, Tina ^a   Maier, Christoph ^b   Enax Krumova, Elena K ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Corneal confocal microscopy; Diagnostic procedures; Neuropathic pain; Quantitative sensory testing; Skin biopsy

Indexed keywords

CAPSAICIN; LIDOCAINE; OXCARBAZEPINE; PREGABALIN;

CLINICAL PRACTICE; CLINICAL RESEARCH; CONFOCAL MICROSCOPY; DIABETIC NEUROPATHY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; EVOKED RESPONSE; FIBROMYALGIA; HUMAN; LABORATORY TEST; NERVE CONDUCTION; NERVE FIBER; NEUROGRAPHY; NEUROPATHIC PAIN; NEUROPATHY; NON INVASIVE PROCEDURE; PAIN ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SARCOIDOSIS; SENSORY ANALYSIS; SKIN BIOPSY; SKIN NERVE; SOMATOSENSORY SYSTEM; NEURALGIA; NEUROLOGIC EXAMINATION; PAIN MEASUREMENT; PROCEDURES;

HUMANS; NEURALGIA; NEUROLOGIC EXAMINATION; PAIN MEASUREMENT;

EID: 84973464850     PISSN: 09527907     EISSN: 14736500     Source Type: Journal    
DOI: 10.1097/ACO.0000000000000223     Document Type: Review

References (75)

1. Jensen TS, Baron R, Haanpää M, et al. A new definition of neuropathic pain. Pain 2011;152:2204-2205.
2. Treede RD, Jensen TS, Campbell JN, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008;70:1630-1635.
3. Backonja MM, Attal N, Baron R, et al. Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus. Pain 2013;154:1807-1819.
4. Lauria G, Lombardi R. Skin biopsy in painful and immune-mediated neuropathies. J Peripher Nerv Syst 2012; 17 (SUPPL. 3):38-45.
5. Lauria G, Hsieh ST, Johansson O, et al. European Federation of Neurological Societies; Peripheral Nerve Society. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 2010;17:903-912.
6. Mellgren SI, Nolano M, Sommer C. The cutaneous nerve biopsy: technical aspects, indications, and contribution. Hanndb Clin Neurol 2013;115:171-188.
7. Jiang MS, Yuan Y, Gu ZX, Zhuang SL. Corneal confocal microscopy for assessment of diabetic peripheral neuropathy: a meta-analysis. Br J Ophthalmol 2015 [Epub ahead of print]. doi: 10.1136/bjophthalmol-2014-306038.
8. Maier C, Baron R, Tölle TR, et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes. Pain 2010;150:439-450.
9. Cruccu G, Aminoff MJ, Curio G, et al. Recommendations for the clinical use of somatosensory-evoked potentials. Clin Neurophysiol 2008;119:1705-1719.
10. Cruccu G, Sommer C, Anand P, et al. EFNS guidelines on neuropathic pain assessment: revised 2009. Eur J Neurol 2010;17:1010-1018.
11. Garcia-Larrea L. Objective pain diagnostics: clinical neurophysiology. Neurophysiol Clin 2012;42:187-197.
12. Truini A, Garcia-Larrea L, Cruccu G. Reappraising neuropathic pain in humans: how symptoms help disclose mechanisms. Nat Rev Neurol 2013;9:572-582.
13. Rolke R, Baron R, Maier C, et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain 2006;123:231-243.
14. Magerl W, Krumova EK, Baron R, et al. Reference data for quantitative sensory testing (QST): refined stratification for age and a novel method for statistical comparison of group data. Pain 2010;151:598-605.
15. Pfau DB, Krumova E, Treede RD, et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): reference data for the trunk and application in patients with chronic postherpetic neuralgia. Pain 2014;155:1002-1015.
16. Blankenburg M, Boekens H, Hechler T, et al. Reference values for quantitative sensory testing in children and adolescents: developmental and gender differences of somatosensory perception. Pain 2010;149:76-88.
17. Themistocleous AC, Ramirez JD, Serra J, Bennett DL. The clinical approach to small fibre neuropathy and painful channelopathy. Pract Neurol 2014;14:368-379.
18. Blankenburg M, Kraemer N, Hirschfeld G, et al. Childhood diabetic neuropathy: functional impairment and noninvasive screening assessment. Diabet Med 2012;29:1425-1432.
19. Scherens A, Maier C, Haussleiter IS, et al. Painful or painless lower limb dysesthesias are highly predictive of peripheral neuropathy: comparison of different diagnostic modalities. Eur J Pain 2009;13:711-718.
20. Krøigård T1, Schrøder HD, Qvortrup C, et al. Characterization and diagnostic evaluation of chronic polyneuropathies induced by oxaliplatin and docetaxel comparing skin biopsy to quantitative sensory testing and nerve conduction studies. Eur J Neurol 2014;21:623-629.
21. Stiasny-Kolster K1, Pfau DB, Oertel WH, et al. Hyperalgesia and functional sensory loss in restless legs syndrome. Pain 2013;154:1457-1463.
22. Gierthmühlen J, Maier C, Baron R, et al. German Research Network on Neuropathic Pain (DFNS) study group. Sensory signs in complex regional pain syndrome and peripheral nerve injury. Pain 2012;153:765-774.
23. Mainka T, Bischoff FS, Baron R, et al. Comparison of muscle and joint pressure-pain thresholds in patients with complex regional pain syndrome and upper limb pain of other origin. Pain 2014;155:591-597.
24. Attal N, Bouhassira D, Baron R, et al. Assessing symptom profiles in neuropathic pain clinical trials: can it improve outcome? Eur J Pain 2011;15:441-443.
25. Demant DT, Lund K, Vollert J, et al. The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: a randomised, double-blind, placebo-controlled phenotype-stratified study. Pain 2014;155:2263-2273.
26. Wasner G, Kleinert A, Binder A, et al. Postherpetic neuralgia: topical lidocaine is effective in nociceptor-deprived skin. J Neurol 2005;252:677-686.
27. Mainka T, Malewicz NM, Baron R, et al. Presence of hyperalgesia predicts analgesic efficacy of topically applied capsaicin 8% in patients with peripheral neuropathic pain. Eur J Pain 2015 [Epub ahead of print]. doi: 10.1002/ejp.703.
28. Simpson DM, Schifitto G, Clifford DB, et al., 1066 HIV Neuropathy Study Group. Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial. Neurology 2010;74:413-420.
29. Westermann A, Krumova EK, Pennekamp W, et al. Different underlying pain mechanisms despite identical pain characteristics: a case report of a patient with spinal cord injury. Pain 2012;153:1537-1540.
30. Tampin B, Slater H, Briffa NK. Neuropathic pain components are common in patients with painful cervical radiculopathy, but not in patients with nonspecific neck-arm pain. Clin J Pain 2013;29:846-856.
31. Westermann A, Rönnau AK, Krumova E, et al. Pain-associated mild sensory deficits without hyperalgesia in chronic nonneuropathic pain. Clin J Pain 2011;27:782-789.
32. Wang L, Hilliges M, Jernberg T, et al. Protein gene product 9.5-immunoreactive nerve fibres and cells in human skin. Cell Tissue Res 1990;261:25-33.
33. Kennedy WR, Nolano M, Wendelschafer-Crabb G, et al. Askin blister method to study epidermal nerves in peripheral nerve disease. Muscle Nerve 1999;22:360-371.
34. Panoutsopoulou IG, Wendelschafer-Crabb G, Hodges JS, Kennedy WR. Skin blister and skin biopsy to quantify epidermal nerves: a comparative study. Neurology 2009;72:1205-1210.
35. Lauria G, Dacci P, Lombardi R, et al. Side and time variability of intraepidermal nerve fiber density. Neurology 2015;84:2368-2371.
36. Üçeyler N, Zeller D, Kahn AK, et al. Small fibre pathology in patients with fibromyalgia syndrome. Brain 2013; 136 (Pt 6):1857-1867.
37. Oaklander AL, Herzog ZD, Downs HM, Klein MM. Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia. Pain 2013;154:2310-2316.
38. Giannoccaro MP, Donadio V, Incensi A, et al. Small nerve fiber involvement in patients referred for fibromyalgia. Muscle Nerve 2014;49:757-759.
39. Caro XJ, Winter EF. Evidence of abnormal epidermal nerve fiber density in fibromyalgia: clinical and immunologic implications. Arthritis Rheumatol 2014;66:1945-1954.
40. Levine TD, Saperstein DS. Routine use of punch biopsy to diagnose small fiber neuropathy in fibromyalgia patients. Clin Rheumatol 2015;34:413-417.
41. Truini A, Biasiotta A, Onesti E, et al. Small-fibre neuropathy related to bulbar and spinal-onset in patients with ALS. J Neurol 2015;262:1014-1018.
42. Penza P, Lombardi R, Camozzi F, et al. Painful neuropathy in subclinical hypothyroidism: clinical and neuropathological recovery after hormone replacement therapy. Neurol Sci 2009;30:149-151.
43. Nodera H, Barbano RL, Henderson D, Herrmann DN. Epidermal reinnervation concomitant with symptomatic improvement in a sensory neuropathy. Muscle Nerve 2003;27:507-509.
44. Smith AG, Russell J, Feldman EL, et al. Lifestyle intervention for prediabetic neuropathy. Diabetes Care 2006;29:1294-1299.
45. Singleton JR, Marcus RL, Jackson JE, et al. Exercise increases cutaneous nerve density in diabetic patients without neuropathy. Ann Clin Transl Neurol 2014;1:844-849.
46. Singleton JR, Marcus RL, Lessard MK, et al. Supervised exercise improves cutaneous reinnervation capacity in metabolic syndrome patients. Ann Neurol 2015;77:146-153.
47. Truini A, Biasiotta A, Di Stefano G, et al. Does the epidermal nerve fibre density measured by skin biopsy in patients with peripheral neuropathies correlate with neuropathic pain? Pain 2014;155:828-832.
48. Chen X, Graham J, Dabbah MA, et al. Small nerve fiber quantification in the diagnosis of diabetic sensorimotor polyneuropathy: comparing corneal confocal microscopy with intraepidermal nerve fiber density. Diabetes Care 2015;38:1138-1144.
49. Loavenbruck A, Wendelschaefer-Crabbe G, Sandroni P, Kennedy WR. Quantification of sweat gland volume and innervation in neuropathy: correlation with thermoregulatory sweat testing. Muscle Nerve 2014;50:528-534.
50. Papanas N, Ziegler D. Corneal confocal microscopy: a new technique for early detection of diabetic neuropathy. Curr Diab Rep 2013;13:488-499.
51. Asghar O, Petropoulos IN, Alam U, et al. Corneal confocal microscopy detects neuropathy in subjects with impaired glucose tolerance. Diabetes Care 2014;37:2643-2646.
52. Azmi S, Ferdousi M, Petropoulos IN, et al. Corneal confocal microscopy identifies small-fiber neuropathy in subjects with impaired glucose tolerance who develop type 2 diabetes. Diabetes Care 2015. [Epub ahead of print]
53. Petropoulos IN, Green P, Chan AW, et al. Corneal confocal microscopy detects neuropathy in patients with type 1 diabetes without retinopathy or microalbuminuria. PLoS One 2015;10:e0123517.
54. Petropoulos IN, Alam U, Fadavi H, et al. Corneal nerve loss detected with corneal confocal microscopy is symmetrical and related to the severity of diabetic polyneuropathy. Diabetes Care 2013;36:3646-3651.
55. Tavakoli M, Quattrini C, Abbott C, et al. Corneal confocal microscopy: a novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy. Diabetes Care 2010;33:1792-1797.
56. Kinard KI, Smith AG, Singleton JR, et al. Chronic migraine is associated with reduced corneal nerve fiber density and symptoms of dry eye. Headache 2015;55:543-549.
57. Sturniolo GC, Lazzarini D, Bartolo O, et al. Small fiber peripheral neuropathy in Wilson disease: an in vivo documentation by corneal confocal microscopy. Invest Ophthalmol Vis Sci 2015;56:1390-1395.
58. Schneider C, Bucher F, Cursiefen C, et al. Corneal confocal microscopy detects small fiber damage in chronic inflammatory demyelinating polyneuropathy (CIDP). J Peripher Nerv Syst 2014;19:322-327.
59. Ferrari G, Grisan E, Scarpa F, et al. Corneal confocal microscopy reveals trigeminal small sensory fiber neuropathy in amyotrophic lateral sclerosis. Front Aging Neurosci 2014;6:278.
60. Tavakoli M, Ferdousi M, Petropoulos IN, et al. Normative values for corneal nerve morphology assessed using corneal confocal microscopy: a multinational normative data set. Diabetes Care 2015;38:838-843.
61. Ziegler D, Papanas N, Zhivov A, et al, German Diabetes Study (GDS) Group. Early detection of nerve fiber loss by corneal confocal microscopy and skin biopsy in recently diagnosed type 2 diabetes. Diabetes 2014;63:2454-2463.
62. Tavakoli M, Kallinikos P, Iqbal A, et al. Corneal confocal microscopy detects improvement in corneal nerve morphology with an improvement in risk factors for diabetic neuropathy. Diabet Med 2011;28:1261-1267.
63. Dahan A, Dunne A, Swartjes M, et al. ARA 290 improves symptoms in patients with sarcoidosis-associated small nerve fiber loss and increases corneal nerve fiber density. Mol Med 2013;19:334-345.
64. Merkies IS, Faber CG, Lauria G. Advances in diagnostics and outcome measures in peripheral neuropathies. Neurosci Lett 2015;596:3-13.
65. Katsarava Z, Ayzenberg I, Sack F, et al. A novel method of eliciting pain-related potentials by transcutaneous electrical stimulation. Headache 2006;46:1511-1517.
66. Granovsky Y, Matre D, Sokolik A, et al. Thermoreceptive innervation of human glabrous and hairy skin: a contact heat evoked potential analysis. Pain 2005;115:238-247.
67. Lagerburg V, Bakkers M, Bouwhuis A, et al. Contact heat evoked potentials: Normal values and use in small-fiber neuropathy. Muscle Nerve 2015;51:743-749.
68. Inui K, Kakigi R. Pain perception in humans: use of intraepidermal electrical stimulation. J Neurol Neurosurg Psychiatry 2012;83:551-556.
69. Kodaira M, Inui K, Kakigi R. Evaluation of nociceptive Ad- and C-fiber dysfunction with lidocaine using intraepidermal electrical stimulation. Clin Neurophysiol 2014;125:1870-1877.
70. Obermann M, Katsarava Z, Esser S, et al. Correlation of epidermal nerve fiber density with pain-related evoked potentials in HIV neuropathy. Pain 2008;138:79-86.
71. Mueller D, Obermann M, Koeppen S, et al. Electrically evoked nociceptive potentials for early detection of diabetic small-fiber neuropathy. Eur J Neurol 2010;17:834-841.
72. Donadio V, Liguori R. Microneurographic recording from unmyelinated nerve fibers in neurological disorders: an update. Clin Neurophysiol 2015;126:437-445.
73. Orstavik K, Namer B, Schmidt R, et al. Abnormal function of C-fibers in patients with diabetic neuropathy. J Neurosci 2006;26:11287-11294.
74. Kleggetveit IP, Namer B, Schmidt R, et al. High spontaneous activity of C-nociceptors in painful polyneuropathy. Pain 2012;153:2040-2047.
75. Serra J, Duan WR, Locke C, et al. Effects of a T-type calcium channel blocker, ABT-639, on spontaneous activity in C-nociceptors in patients with painful diabetic neuropathy: a randomized controlled trial. Pain 2015 [Epub ahead of print]. doi: 10.1097/j.pain.0000000000000249.